Literature DB >> 14565956

Critical role of the transcriptional repressor neuron-restrictive silencer factor in the specific control of connexin36 in insulin-producing cell lines.

David Martin1, Thomas Tawadros, Laure Meylan, Amar Abderrahmani, Daniele F Condorelli, Gérard Waeber, Jacques-Antoine Haefliger.   

Abstract

Connexin36 (Cx36) is specifically expressed in neurons and in pancreatic beta-cells. Cx36 functions as a critical regulator of insulin secretion and content in beta-cells. In order to identify the molecular mechanisms that control the beta-cell expression of Cx36, we initiated the characterization of the human 5' regulatory region of the CX36 gene. A 2043-bp fragment of the human CX36 promoter was identified from a human BAC library and fused to a luciferase reporter gene. This promoter region was sufficient to confer specific expression to the reporter gene in insulin-secreting cell lines. Within this 5' regulatory region, a putative neuron-restrictive silencer element conserved between rodent and human species was recognized and binds the neuron-restrictive silencing factor (NRSF/REST). This factor is not expressed in insulin-secreting cells and neurons; it functions as a potent repressor through the recruitment of histone deacetylase to the promoter of neuronal genes. The NRSF-mediated repression of Cx36 in HeLa cells was abolished by trichostatin A, confirming the functional importance of histone deacetylase activity. Ectopic expression, by viral gene transfer, of NRSF/REST in different insulin-secreting beta-cell lines induced a marked reduction in Cx36 mRNA and protein content. Moreover, mutations in the Cx36 neuron-restrictive silencer element relieved the low transcriptional activity of the human CX36 promoter observed in HeLa cells and in INS-1 cells expressing NRSF/REST. The data showed that cx36 gene expression in insulin-producing beta-cell lines is strictly controlled by the transcriptional repressor NRSF/REST indicating that Cx36 participates to the neuronal phenotype of the pancreatic beta-cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14565956     DOI: 10.1074/jbc.M306861200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Cx36 is a target of Beta2/NeuroD1, which associates with prenatal differentiation of insulin-producing β cells.

Authors:  Rachel Nlend Nlend; Aouatef Aït-Lounis; Florent Allagnat; Valentina Cigliola; Anne Charollais; Walter Reith; Jacques-Antoine Haefliger; Paolo Meda
Journal:  J Membr Biol       Date:  2012-06-23       Impact factor: 1.843

2.  Functional diversity for REST (NRSF) is defined by in vivo binding affinity hierarchies at the DNA sequence level.

Authors:  Alexander W Bruce; Andrés J López-Contreras; Paul Flicek; Thomas A Down; Pawandeep Dhami; Shane C Dillon; Christoph M Koch; Cordelia F Langford; Ian Dunham; Robert M Andrews; David Vetrie
Journal:  Genome Res       Date:  2009-04-28       Impact factor: 9.043

Review 3.  Gap junctions.

Authors:  Morten Schak Nielsen; Lene Nygaard Axelsen; Paul L Sorgen; Vandana Verma; Mario Delmar; Niels-Henrik Holstein-Rathlou
Journal:  Compr Physiol       Date:  2012-07       Impact factor: 9.090

4.  No REST for healthy beta cells.

Authors:  G Thiel; F Schuit
Journal:  Diabetologia       Date:  2008-08       Impact factor: 10.122

5.  The RE1 binding protein REST regulates oligodendrocyte differentiation.

Authors:  Lisa Evans Dewald; Justin P Rodriguez; Joel M Levine
Journal:  J Neurosci       Date:  2011-03-02       Impact factor: 6.167

6.  Neuron-enriched RNA-binding Proteins Regulate Pancreatic Beta Cell Function and Survival.

Authors:  Jonàs Juan-Mateu; Tatiana H Rech; Olatz Villate; Esther Lizarraga-Mollinedo; Anna Wendt; Jean-Valery Turatsinze; Letícia A Brondani; Tarlliza R Nardelli; Tatiane C Nogueira; Jonathan L S Esguerra; Maria Inês Alvelos; Piero Marchetti; Lena Eliasson; Décio L Eizirik
Journal:  J Biol Chem       Date:  2017-01-11       Impact factor: 5.157

Review 7.  New insights into the role of connexins in pancreatic islet function and diabetes.

Authors:  Nikki L Farnsworth; Richard K P Benninger
Journal:  FEBS Lett       Date:  2014-02-28       Impact factor: 4.124

8.  Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes.

Authors:  Judith Miklossy; Hong Qing; Aleksandra Radenovic; Andras Kis; Bertrand Vileno; Forró Làszló; Lisa Miller; Ralph N Martins; Gerard Waeber; Vincent Mooser; Fred Bosman; Kamel Khalili; Nune Darbinian; Patrick L McGeer
Journal:  Neurobiol Aging       Date:  2008-10-23       Impact factor: 4.673

9.  Functional significance of repressor element 1 silencing transcription factor (REST) target genes in pancreatic beta cells.

Authors:  D Martin; F Allagnat; G Chaffard; D Caille; M Fukuda; R Regazzi; A Abderrahmani; G Waeber; P Meda; P Maechler; J-A Haefliger
Journal:  Diabetologia       Date:  2008-04-03       Impact factor: 10.122

10.  REST represses a subset of the pancreatic endocrine differentiation program.

Authors:  David Martin; Yung-Hae Kim; Dror Sever; Chai-An Mao; Jacques-Antoine Haefliger; Anne Grapin-Botton
Journal:  Dev Biol       Date:  2015-07-05       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.